Skip to content
Disclosery

SABBY MANAGEMENT, LLC

Follow

13F filer, CIK 1535610, MIAMI BEACH, FL

SABBY MANAGEMENT, LLC reported $186,418,286 across 42 holdings for the quarter ended 2024-09-30, in a 13F-HR filed 2024-11-14. Its ten largest share positions make up 88.19% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001104659-24-118349

Period
2024-09-30
Reported value
$186M
Holdings
42
Top 10 weight
88.19%
New
23
Sold out
20

Largest buys vs the previous quarter

SecurityShares changeApprox. value
Volcon Inc (US) OLDnew+774,569$806K
HCWCnew+302,876$754K
IMUNON INCnew+608,203$645K
CORZnew+34,001$403K
PINEAPPLE ENERGY INCnew+2,779,177$373K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CORZWexited-168,974-$762K
REDHILL BIOPHARMA LTDexited-1,341,189-$497K
GREENWAVE TECHNOLOGY SOLUTIOexited-229,472-$406K
ELTKexited-40,565-$396K
IWMexited-1,500-$304K

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2024

Share positions as resolved from 13F-HR 0001104659-24-118349, largest first. % of portfolio is the value over $7,218,869, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
VANIVIVANI MEDICAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,128,042 shares 2,128,042$2.49M34.49%+1,866Timeline
Volcon Inc (US) OLDVolcon Inc (US) OLDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 774,569 shares 774,569$806K11.16%new
HCWCHEALTHY CHOICE WELLNESS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 302,876 shares 302,876$754K10.45%newTimeline
IMUNON INCIMUNON INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 608,203 shares 608,203$645K8.93%new
CORZCORE SCIENTIFIC INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 34,001 shares 34,001$403K5.59%newTimeline
PINEAPPLE ENERGY INCPINEAPPLE ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,779,177 shares 2,779,177$373K5.16%new
Ensysce Biosciences IncEnsysce Biosciences IncQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 1,162,592 shares 1,162,592$279K3.87%+848,239
SCPXSCORPIUS HLDGS INC COM PAR $0.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 346,256 shares 346,256$249K3.45%newTimeline
ELEVAI LABS INCELEVAI LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 2,541,779 shares 2,541,779$211K2.92%new
ATXIAVENUE THERAPEUTICS INC COM PAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 63,060 shares 63,060$157K2.18%+25,666Timeline
SNESSENESTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 55,639 shares 55,639$144K1.99%newTimeline
FOCUS UNVL INCFOCUS UNVL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 500,798 shares 500,798$132K1.83%new
HAOXI HEALTH TECHNOLOGY LTDHAOXI HEALTH TECHNOLOGY LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 347,413 shares 347,413$125K1.73%new
PHIOPHIO PHARMACEUTICALS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,131 shares 25,131$86.7K1.2%newTimeline
SIDUSIDUS SPACE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,098 shares 30,098$84.3K1.17%-53,002Timeline
NRXPNRX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 35,049 shares 35,049$59.2K0.82%newTimeline
VVOSVIVOS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 20,502 shares 20,502$53.5K0.74%newTimeline
BLUEJAY DIAGNOSTICS INCBLUEJAY DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 305,224 shares 305,224$38.8K0.54%new
REVELATION BIOSCIENCES INCREVELATION BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 42,226 shares 42,226$36K0.5%new
SPCBSUPERCOM LTD NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 9,360 shares 9,360$35.2K0.49%newTimeline
KPRXKIORA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,000 shares 5,000$18.3K0.25%newTimeline
SXTPW60 DEGREES PHARMACEUTICALS IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 271,128 shares 271,128$15.5K0.22%-24,461Timeline
AMPLITECH GROUP INCAMPLITECH GROUP INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 197,378 shares 197,378$7.89K0.11%-135,338
Femto Technologies Inc (US)…Femto Technologies Inc (US) OLDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 898 shares 898$7.2K0.1%new
SCILEX HOLDING COSCILEX HOLDING COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 4,023 shares 4,023$3.72K0.05%new
WEARABLE DEVICES LTDWEARABLE DEVICES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 148,717 shares 148,717$2.96K0.04%-74,372
EFTREFFECTOR THERAPEUTICS INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2022Q4: restricted; 2023Q1: restricted; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 61,758 shares 61,758$2.29K0.03%-290,326Timeline

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T PUTput1,247$71.5M+153
STATE STR SPDR S&P 500 ETF TSTATE STR SPDR S&P 500 ETF T CALLcall749$43M+445
ISHARES TRISHARES TR PUTput1,876$41.4M-635
ISHARES TRISHARES TR CALLcall458$10.1M+164
CORE SCIENTIFIC INC NEWCORE SCIENTIFIC INC NEW PUTput7,513$8.91M+1,605
BIT DIGITAL INCBIT DIGITAL INC SHSput6,244$2.19M+1,936
EOS ENERGY ENTERPRISES INCEOS ENERGY ENTERPRISES INC PUTput3,227$958K+2,716
CORE SCIENTIFIC INC NEWCORE SCIENTIFIC INC NEW CALLcall419$497K-75
CHECKPOINT THERAPEUTICS INCCHECKPOINT THERAPEUTICS INC COMput1,761$394K-947
NRX PHARMACEUTICALS INCNRX PHARMACEUTICALS INC PUTput768$130K+238
GLOBUS MARITIME LIMITED NEWGLOBUS MARITIME LIMITED NEW PUTput91$17.5K0
REVIVA PHARMACEUTCLS HLDGS …REVIVA PHARMACEUTCLS HLDGS INC COMput94$13.5Knew
SCILEX HOLDING COSCILEX HOLDING CO PUTput43$3.98Knew
SAFETY SHOT INCSAFETY SHOT INC COM NEWput26$3.17Knew
ATOSSA THERAPEUTICS INCATOSSA THERAPEUTICS INC COMput9$1.37Knew

Sold out in Q3 2024

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CORZWCORE SCIENTIFIC INC NEW168,974$762Kshares
REDHILL BIOPHARMA LTDREDHILL BIOPHARMA LTD1,341,189$497Kshares
GREENWAVE TECHNOLOGY SOLUTIOGREENWAVE TECHNOLOGY SOLUTIO229,472$406Kshares
ELTKELTEK LTD40,565$396Kshares
IWMISHARES TR1,500$304Kshares
Reviva Pharmaceuticals Hold…Reviva Pharmaceuticals Holdings I…236,997$303Kshares
BIOVIE INCBIOVIE INC733,055$294Kshares
LIPELLA PHARMACEUTICALS INCLIPELLA PHARMACEUTICALS INC540,250$243Kshares
SONNET BIOTHERAPEUTC HLDNG ISONNET BIOTHERAPEUTC HLDNG I238,395$223Kshares
APTEVO THERAPEUTICS INCAPTEVO THERAPEUTICS INC501,499$153Kshares
GEVOGEVO INC250,000$139Kshares
NEXIMMUNE INCNEXIMMUNE INC49,904$138Kshares
SMFLSMART FOR LIFE INC COM PAR $0.34,504$102Kshares
CHINA NATURAL RESOURCES INCCHINA NATURAL RESOURCES INC104,931$82.2Kshares
INMED PHARMACEUTICALS INCINMED PHARMACEUTICALS INC307,236$81.6Kshares
GEVO INCGEVO INC1,258$70.1Kcall
SCNISCINAI IMMUNOTHERAPEUTICS LT17,828$49.6Kshares
APPLIED DNA SCIENCES INCAPPLIED DNA SCIENCES INC70,463$28.8Kshares
SUNSHINE BIOPHARMA INCSUNSHINE BIOPHARMA INC20,000$8.35Kshares
CINGWCINGULATE INC458,522$4.95Kshares

How Q3 2024 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001104659-24-118349 base2024-11-14acceptance time not in the bulk data set